Medivir AB (publ)
MVRBF · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 109.8% | 120% | 0% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -795.8% | -1,272.7% | -4,280% | -6,280% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -782.7% | -1,345.5% | -4,620% | -6,540% |
| EPS Diluted | -0.32 | -0.27 | -0.41 | -0.59 |
| % Growth | -18.5% | 34.1% | 30.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |